Top compounds associated with response to LDHD


Feature Type Standardized
Nominal ANOVA
mRNA SL 0101-1 GDSC1000 pan-cancer AAC 0.0013 1
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0011 1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.00098 1
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.0011 1
mRNA AM-580 CTRPv2 pan-cancer AAC 0.0011 1
mRNA NSC95397 CTRPv2 pan-cancer AAC -0.00097 1
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC 0.0014 1
mRNA Crizotinib CCLE pan-cancer AAC -0.0012 1
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.0011 1
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.00078 1
Download CSV